Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 1
1982 2
1986 1
1988 2
1990 1
1991 1
1993 4
1994 1
1995 3
1996 1
1997 3
1998 2
1999 3
2000 5
2001 1
2002 3
2003 5
2004 3
2005 1
2006 5
2007 2
2008 2
2009 4
2010 2
2011 3
2012 5
2013 5
2014 3
2015 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group; Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK. International Collaboration of Trialists, et al. J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502557 Free PMC article. Clinical Trial.
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
START Trialists' Group; Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. START Trialists' Group, et al. Lancet. 2008 Mar 29;371(9618):1098-107. doi: 10.1016/S0140-6736(08)60348-7. Epub 2008 Mar 19. Lancet. 2008. PMID: 18355913 Free PMC article. Clinical Trial.
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
START Trialists' Group; Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. START Trialists' Group, et al. Lancet Oncol. 2008 Apr;9(4):331-41. doi: 10.1016/S1470-2045(08)70077-9. Epub 2008 Mar 19. Lancet Oncol. 2008. PMID: 18356109 Free PMC article. Clinical Trial.
The management of children with lymphomas.
Frew JA, Lewis J, Lucraft HH. Frew JA, et al. Among authors: lucraft hh. Clin Oncol (R Coll Radiol). 2013 Jan;25(1):11-8. doi: 10.1016/j.clon.2012.09.009. Epub 2012 Dec 8. Clin Oncol (R Coll Radiol). 2013. PMID: 23231943 Review.
Guidelines for supportive care in multiple myeloma 2011.
Snowden JA, Ahmedzai SH, Ashcroft J, D'Sa S, Littlewood T, Low E, Lucraft H, Maclean R, Feyler S, Pratt G, Bird JM; Haemato-oncology Task Force of British Committee for Standards in Haematology and UK Myeloma Forum. Snowden JA, et al. Among authors: lucraft h. Br J Haematol. 2011 Jul;154(1):76-103. doi: 10.1111/j.1365-2141.2011.08574.x. Epub 2011 Apr 22. Br J Haematol. 2011. PMID: 21517805 Free article. Review.
Optimizing the management of differentiated thyroid cancer.
Mallick UK, Lucraft H, Proud G, Perros P, Fenwick J, Kendall-Taylor P, Johnson S, Lennard T, Ball S, James RA, Douglas F, Weightman DR. Mallick UK, et al. Among authors: lucraft h. Clin Oncol (R Coll Radiol). 2000;12(6):363-4. doi: 10.1053/clon.2000.9195. Clin Oncol (R Coll Radiol). 2000. PMID: 11202089 No abstract available.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control.
Proctor SJ, Lennard AL, Jackson GH, Jones GL, Lewis J, Wilkinson J, White J, Sieniawski M, McKay P, Culligan D, Lucraft HH. Proctor SJ, et al. Among authors: lucraft hh. Ann Oncol. 2010 Feb;21(2):426-428. doi: 10.1093/annonc/mdp527. Epub 2009 Nov 9. Ann Oncol. 2010. PMID: 19901016 Free article. Review. No abstract available.
Brachial plexus neuropathy following mantle radiotherapy.
Wadd NJ, Lucraft HH. Wadd NJ, et al. Among authors: lucraft hh. Clin Oncol (R Coll Radiol). 1998;10(6):399-400. doi: 10.1016/s0936-6555(98)80040-x. Clin Oncol (R Coll Radiol). 1998. PMID: 9890543
Risk of premature menopause after treatment for Hodgkin's lymphoma.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister A, Lucraft HH, Radford J, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group. Swerdlow AJ, et al. Among authors: lucraft hh. J Natl Cancer Inst. 2014 Aug 19;106(9):dju207. doi: 10.1093/jnci/dju207. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25139687
70 results